Brief: Sol-Gel Announces Pipeline Update And Future Development Plans

SOL-GEL TECHNOLOGIES

28/06/2021 10:14

June 28 (Reuters) - Sol Gel Technologies Ltd  SLGL.O :
    * ANNOUNCES PIPELINE UPDATE AND FUTURE DEVELOPMENT PLANS
    * SOL GEL TECHNOLOGIES-INVESTIGATIONAL SGT-510 WAS FOUND TO
BE
MORE EFFECTIVE THAN ROFLUMILAST CREAM, 0.3%, IN A HUMAN
XENOGRAFT PSORIASIS ANIMAL MODEL
    * SOL-GEL FILED A PROVISIONAL PATENT APPLICATION FOR ITS
NOVEL AND
NON-OBVIOUS FORMULATION OF SGT-510
    * PROOF-OF-CONCEPT STUDY FOR SGT-210 (ERLOTINIB GEL) IN
PALMOPLANTAR KERATODERMA PATIENTS COMPLETED, INDICATED POSSIBLE
MODEST IMPROVEMENT
    * BY 2022 END, CO EXPECTS TO HAVE DATA AGAINST A FORMULATION
OF
ROFLUMILAST CREAM, EXPECTS TO INITIATE PHASE 2 WORK THEREAFTER

Source text for Eikon:  ID:nGNX9jGsr7 
Further company coverage:  SLGL.O 

 ((Reuters.Briefs@thomsonreuters.com;))